تست عنوان
close
FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Registration Date 9 Nov 2016

BRAF inhibitor

Medicine Pharmaceuticals

Antineoplastic Agent

Applications

Cancer therapies

Properties

Our lead compounds exhibited potency against various targets that are essential for tumor cell proliferation. Animal models study data show that they are at least equivalent to, and in most cases superior to, competing clinical & marketed molecules.

Manufacturer's Description

Our primary research efforts are centered on cancer therapies.  Using highly effective structural approaches, we have developed 5 pre-clinical oncology candidates.